• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Biocon`s Generics Daptomycin Receives Approval in US

    FDA

    Fresenius Kabi USA`s Generics Daptomycin Receives Approval in US

    FDA

    Olon Celebrates 10 Years of Daptomycin

    CONTRACT PHARMA

    Mylan`s Generic Daptomycin Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of March 8, 2023

    FDA

    Enforcement Report - Week of February 22, 2023

    FDA

    Enforcement Report - Week of January 25, 2023

    FDA

    Aspiro`s Generic Daptomycin Receives Approval in the U.S.

    FDA

    Accord Healthcare Inc. Issues Nationwide Voluntary Recall of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial Lot # R2200232 Due to Product Mix-up

    PRNEWSWIRE

    ContraFect calls for antibiotic study after `uninterpretable` PIII result

    ENDPTS

    ERADICATE phase 3 study results highlight the potential role of ceftobiprole

    GLOBENEWSWIRE

    Aspiro`s Generic Daptomycin Receives Approval in the U.S.

    FDA

    Hainan`s Generic Daptomycin Receives Approval in the U.S.

    FDA

    Hangzhou Zhongmei `s Generic Daptomycin Receives Approval in US

    FDA

    Enforcement Report - Week of November 11, 2021

    FDA

    Merck Issues Voluntary Nationwide Recall of CUBICIN® (Daptomycin for Injection)

    PRESS RELEASE

    Merck Issues Voluntary Nationwide Recall of CUBICIN 500 mg

    BUSINESSWIRE

    Aurobindo Pharma`s Generic Daptomycin receives Approval in the US

    FDA

    Genentech`s Generic Daptomycin Receives Approval in the U.S

    FDA

    Hong Kong`s Generic Daptomycin Receives Approval in the U.S

    FDA

    Hisun Pharm Hangzhou`s Generic Daptomycin Receives Approval In US

    FDA

    Dr Reddys Lab`s Generic Daptomycin Receives Approval in US

    FDA

    B Pharms`s Generic Daptomycin Receives Approval In US

    FDA

    Enforcement Report - Week of August 12, 2020

    FDA

    Mylan recalls daptomycin after particulates show up in vial

    FIERCE PHARMA

    Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection

    FDA

    Sandoz acquires US distribution rights to two key hospital injectable medicines

    PR NEWSWIRE

    Cipla Announces Launch of Daptomycin for Injection

    PR NEWSWIRE

    Cipla launches skin treatment drug in US

    MONEYCONTROL

    Jiangsu Hengrui’s Generic Daptomycin Receives Approval In US

    FDA

    ACCORD HEALTHCARE`s generic DAPTOMYCIN Receives Approval in US

    FDA

    Ohio facility sees new life as Xellia moves production from North Carolina

    IN PHARMATECHNOLOGIST

    A Deeper Understanding of Alzheimer’s

    BIOSPACE

    BE PHARMS Generic Daptomycin Receives Approval In US

    FDA

    Accord Healthcare`s Generic Daptomycin Receives Approval In US

    FDA

    Merck scores a new Zerbaxa indication

    FIERCE PHARMA

    Dr. Reddy`s Laboratories announces the launch of Daptomycin for Injection

    BUSINESSWIRE

    Anvisa registers new generic drugs

    ANVISA

    FDA Confirms Paragraph IV Patent Challenge of Cubicin RF 21572 (Daptomycin) For Injection

    FDA

    Updated List of New Paragraph IV Patent Certifications - Oct 22

    FDA

    List of centrally authorised products requiring a notification of a change for update of annexes

    EMA

    Enforcement Report - Week of August 8, 2018

    FDA

    Mylan Labs Generic Daptomycin Receives Approval In US

    FDA

    Fresenius Kabi Announces Approval & Immediate Availability of Daptomycin for Inj

    BUSINESSWIRE

    Fresenius Kabi USA Generic Daptomycin Receives Approval In US

    FDA

    Hospira UK Limited Daptomycin Hospira (daptomycin) Receives Approval In Europe

    EMA

    Merck falls short in Q4 sales but sees EPS growth ahead

    FIERCE PHARMA

    Eight medicines leap towards EU approval

    PHARMATIMES

    Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers

    FIERCE PHARMA

    Teva Pharma introduces generic Cubicin in US market

    PHARMABIZ

    Crane Pharmaceuticals` Generic Daptomycin Approved in US for Antibacterial Infections

    FDA

    US FDA Enforcement Report- 8/June/2016

    FDA

    Teva Parenteral`s Generic Daptomycin approved in US as an antibacterial agent

    FDA

    Merck finally adds postsurgery med Bridion to US lineup.Will buyer step up?

    FIERCE PHARMA MARKETING

    Merck may appeal to Supreme Court after losing fight to protect Cubicin patents

    FIERCE PHARMA

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    Hospira`s Daptomycin Tentatively Approved in USA for Complicated Skin Infections, Bacteremia and Endocarditis

    FDA

    Walgreens Infusion Services, Ongoing Class II recall of Daptomycin various strengths in normal saline bags because of Lack of sterility assurance.

    FDA

    Cubist has its Zerbaxa OK. Can Merck Make the Launch Justify its $9.5B Buyout?

    FIERCE PHARMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.